85 results on '"Tripathy, Sasmita"'
Search Results
2. TLBO Based Optimized Planning Framework of Distribution Network considering Electric Vehicle Charging Station and Solar Photovoltaic System
3. Optimized planning framework of solar photovoltaic based generation with EV charging station in a rural distribution network considering uncertainties
4. Computer-Aided Analysis of Solidification Time and its Effect on Hardness for Aluminium Copper Alloy
5. Yield and quality of dry direct-seeded rice (Oryza sativa) as influenced by nitrogen and weed management practices in Eastern India
6. Effect of row ratios and organic nutrient management on productivity and economics of Indian mustard (Brassica juncea) + chickpea (Cicer arietinum) intercropping system
7. Data from ANG4043, a Novel Brain-Penetrant Peptide–mAb Conjugate, Is Efficacious against HER2-Positive Intracranial Tumors in Mice
8. Supplemental Figure 3 from ANG4043, a Novel Brain-Penetrant Peptide–mAb Conjugate, Is Efficacious against HER2-Positive Intracranial Tumors in Mice
9. Supplemental Figure 2 from ANG4043, a Novel Brain-Penetrant Peptide–mAb Conjugate, Is Efficacious against HER2-Positive Intracranial Tumors in Mice
10. Supplemental Figure 3 from ANG4043, a Novel Brain-Penetrant Peptide–mAb Conjugate, Is Efficacious against HER2-Positive Intracranial Tumors in Mice
11. Supplemental Figure 1 from ANG4043, a Novel Brain-Penetrant Peptide–mAb Conjugate, Is Efficacious against HER2-Positive Intracranial Tumors in Mice
12. Supplemental Figure 2 from ANG4043, a Novel Brain-Penetrant Peptide–mAb Conjugate, Is Efficacious against HER2-Positive Intracranial Tumors in Mice
13. Data from ANG4043, a Novel Brain-Penetrant Peptide–mAb Conjugate, Is Efficacious against HER2-Positive Intracranial Tumors in Mice
14. Supplemental Figure Legends from ANG4043, a Novel Brain-Penetrant Peptide–mAb Conjugate, Is Efficacious against HER2-Positive Intracranial Tumors in Mice
15. Supplemental Figure 4 from ANG4043, a Novel Brain-Penetrant Peptide–mAb Conjugate, Is Efficacious against HER2-Positive Intracranial Tumors in Mice
16. Supplemental Figure Legends from ANG4043, a Novel Brain-Penetrant Peptide–mAb Conjugate, Is Efficacious against HER2-Positive Intracranial Tumors in Mice
17. Supplemental Figure 1 from ANG4043, a Novel Brain-Penetrant Peptide–mAb Conjugate, Is Efficacious against HER2-Positive Intracranial Tumors in Mice
18. Supplemental Figure 4 from ANG4043, a Novel Brain-Penetrant Peptide–mAb Conjugate, Is Efficacious against HER2-Positive Intracranial Tumors in Mice
19. Jal Neti and Ushna Jal Paan as Pathya in Vataja Pratishyaya wsr Allergic Rhinitis
20. CRITICAL REVIEW OF JAL IN ANCIENT AND AYURVEDA CLASSICS
21. Effect of Kunjal (Vamana Dhauti ) and Amalaki Mudaga As A Pathya In Urdhwaga Amlapitta WSR Acid-Peptic Disease
22. THE GLIMPS OF USHNODAKA AND KWATHITA SHEETA JAL IN AYURVEDA : A REVIEW
23. Effect of Copper Addition on Tensile Behaviour of Al-Cu Alloy Used in High Temperature Applications
24. Impact Assessment of PV Penetration on Unbalanced Distribution network with Dynamic load condition
25. Modeling of EV Load and Its Impacts on the Distribution System for Static Condition
26. Role of Retinoic Acid-Metabolizing Cytochrome P450s, CYP26, in Inflammation and Cancer
27. EFFICACY OF AABHADI CHURNA ALONG WITH PATHYA AAHARA AND VIHARA IN GRIDHRASI W.S.R. TO SCIATICA - A RESEARCH ARTICLE
28. Productivity and economics of rice (Oryza sativa) through phosphorus management in North-East India
29. Power Quality Improvement of Grid Connected Wind System with STATCOM
30. Corrigendum to “In vitro to in vivo extrapolation of the complex drug-drug interaction of bupropion and its metabolites with CYP2D6; simultaneous reversible inhibition and CYP2D6 downregulation” [Biochem. Pharmacol. 123(2017)85–96]
31. A REVIEW ON EFFECT OF PRANAYAMA ON MENTAL HEALTH DURING COVID-19
32. A REVIEW ON EFFECT OF YOGA ON OBESITY
33. PREVENTION OF ALCOHOL ADDICTION THROUGH AYURVEDA – A REVIEW ARTICLE
34. Cascaded Controlled Converter System for Grid Connected Variable Speed Wind Generator
35. Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease
36. Inhibition of the all-trans Retinoic Acid (atRA) Hydroxylases CYP26A1 and CYP26B1 Results in Dynamic, Tissue-Specific Changes in Endogenous atRA Signaling
37. Tissue Specific Regulation of CYP26 Enzymes
38. In vitro to in vivo extrapolation of the complex drug-drug interaction of bupropion and its metabolites with CYP2D6; simultaneous reversible inhibition and CYP2D6 downregulation
39. A teaching learning based optimization technique for optimal location and size of DG in distribution network
40. CYP26 Inhibition Increases Retinoic Acid Concentrations in Target Tissues and Alters Retinoid Signaling
41. Retinoic Acid Metabolites and Isomers have Differential Effects on Lipid Metabolism
42. Development and Characterization of Novel and Selective Inhibitors of Cytochrome P450 CYP26A1, the Human Liver Retinoic Acid Hydroxylase
43. All-Trans-Retinoic Acid Enhances Mitochondrial Function in Models of Human Liver
44. Potential for Dietary ω-3 Fatty Acids to Prevent Nonalcoholic Fatty Liver Disease and Reduce the Risk of Primary Liver Cancer
45. Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr−/− mice
46. Abstract 2465: Targeting HER2-positive brain metastases by incorporating the brain-penetrant Angiopep-2 peptide to an anti-HER2 antibody and anti-HER2 antibody drug conjugate
47. All‐trans‐retinoic Acid ( at RA) Enhances Mitochondrial Biogenesis in Models of Human Liver
48. ANG4043, a Novel Brain-Penetrant Peptide–mAb Conjugate, Is Efficacious against HER2-Positive Intracranial Tumors in Mice
49. Induction of CYP26A1 by Metabolites of Retinoic Acid: Evidence That CYP26A1 Is an Important Enzyme in the Elimination of Active Retinoids
50. Abstract 2657: Utilization of the Angiopep platform to enable brain penetration of therapeutic mAbs or Antibody-Drug Conjugates for treatment of brain tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.